市場調查報告書

支氣管炎治療的全球市場:2020-2026年

Global Bronchitis Treatment Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949658
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
支氣管炎治療的全球市場:2020-2026年 Global Bronchitis Treatment Market 2020-2026
出版日期: 2020年06月27日內容資訊: 英文
簡介

全球支氣管炎治療的市場在預測期間內預計顯示相當的成長。由於老年人口的增加和大氣污染,氣喘及慢性阻塞性肺病 (COPD)的盛行率增加,這些要素促進該市場的成長。在藥物區分中,預計支氣管擴張藥在預測期間內顯示高年複合成長率。各地區中,北美地區預計佔大幅佔有率,高度成熟已開發具有醫療基礎設施的美國對先進治療解決方案的開發有所貢獻。還有由於總人的增加,老年人口增加,工業化加速與其伴隨的大氣污染等級上升等要素,亞太地區在預測期間內預計表現高成長率。

本報告提供全球支氣管炎治療的市場調查,市場定義和概要,市場成長的各種影響因素分析,相關法律,市場規模的變化、預測,治療區分等各種區分的明細,各地區、主要國家的詳細分析,競爭環境,企業佔有率,主要企業簡介等資訊彙整。

第1章 報告概要

第2章 市場概要、考察

  • 調查範圍
  • 分析師的見解、目前市場趨勢
  • 法律規章

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的發展

第4章 市場影響因素

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第5章 市場分析、預測:各種區分

  • 各類型
    • 藥物
    • 氧氣療法

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Dr Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals, Inc.
  • Mayne Pharma Group Ltd.
  • Merck & Co., Inc.
  • Mucinex (Reckitt Benckiser Group plc)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
目錄
Product Code: OMR2021977

Global Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026

The global bronchitis treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the rising geriatric population and air pollution, which in turn, is increasing the prevalence of asthma and chronic obstructive pulmonary disease (COPD) across the globe. With the rise in these respiratory diseases, the incidence rate of bronchitis increases, which in turn, is offering growth to the market across the globe. The bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period.

Geographically, the global bronchitis treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and developed healthcare infrastructure, contributes to the development of advanced treatment solution for bronchitis. The US has a high spending on healthcare R&D and high prevalence of asthma, which in turn, offers growth to the bronchitis treatment market in North America. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rising population leading to the rise in geriatric population and increase in industrial sector in the region, especially in India, China, South Korea, and Japan. With the rise in industrialization, the level of air pollution will rise, which in turn, will augment the growth of the bronchitis treatment market in Asia-Pacific.

The global bronchitis treatment market is influenced by product development and advancements conducted by the market players. The key players of the bronchitis treatment market include Abbott Laboratories, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These players are playing a significant role in the growth of the bronchitis treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global bronchitis treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Bronchitis Treatment Market Research and Analysis by Type

The Report Covers:

  • Comprehensive research methodology of the global bronchitis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global bronchitis treatment market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Bronchitis Treatment Market by Type
    • 5.1.1. Drugs
      • 5.1.1.1. Antibiotics
      • 5.1.1.2. Anti-inflammatory drugs
      • 5.1.1.3. Bronchodilators
      • 5.1.1.4. Others (Mucolytics)
    • 5.1.2. Oxygen Therapy

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Aurobindo Pharma Ltd.
  • 7.3. Bayer AG
  • 7.4. Boehringer Ingelheim International GmbH
  • 7.5. Cipla Ltd.
  • 7.6. Dr Reddy's Laboratories Ltd.
  • 7.7. GlaxoSmithKline PLC
  • 7.8. Lupin Pharmaceuticals, Inc.
  • 7.9. Mayne Pharma Group Ltd.
  • 7.10. Merck & Co., Inc.
  • 7.11. Mucinex (Reckitt Benckiser Group plc)
  • 7.12. Novartis AG
  • 7.13. Pfizer Inc.
  • 7.14. Sanofi SA
  • 7.15. Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

  • 1. GLOBAL BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL BRONCHITIS TREATMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL BRONCHITIS TREATMENT OXYGEN THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)

4. GLOBAL BRONCHITIS TREATMENT OXYGEN THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-

  • 5. GLOBAL BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 6. NORTH AMERICAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 7. NORTH AMERICAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 8. EUROPEAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 9. EUROPEAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 10. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 11. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 12. REST OF THE WORLD BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BRONCHITIS TREATMENT MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL BRONCHITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 3. US BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 4. CANADA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. UK BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. FRANCE BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. GERMANY BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. ITALY BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. SPAIN BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ROE BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. INDIA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CHINA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. JAPAN BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF THE WORLD BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)